EXPERT CONSENSUS. ROLE OF COMBINATION LIPID-LOWERING THERAPY (SIMVASTATIN/EZETIMIBE 20/10 MG) IN THE CORRECTION OF LIPID METABOLISM DISTURBANCES IN PATIENTS WITH CHRONIC KIDNEY DISEASE

A. Catapano; E. V. Shlyakhto; A. I. Martynov; R. G. Oganov; V. V. Kukharchuk; M. V. Shestakova; A. S. Ametov; S. A. Boicov; M. G. Bubnova; S. V. Villevalde; A. S. Galyavich; Yu. A. Karpov; J. D. Kobalava; O. N. Koziolova

For citations:

Catapano A., Shlyakhto E.V., Martynov A.I., Oganov R.G., Kukharchuk V.V., Shestakova M.V., Ametov A.S., Boicov S.A., Bubnova M.G., Villevalde S.V., Galyavich A.S., Karpov Yu.A., Kobalava J.D., Koziolova O.N. EXPERT CONSENSUS. ROLE OF COMBINATION LIPID-LOWERING THERAPY (SIMVASTATIN/EZETIMIBE 20/10 MG) IN THE CORRECTION OF LIPID METABOLISM DISTURBANCES IN PATIENTS WITH CHRONIC KIDNEY DISEASE. Cardiovascular Therapy and Prevention. 2013;12(4):75-78. (In Russ.) https://doi.org/10.15829/1728-8800-2013-4-75-78

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Cardiovascular Therapy and Prevention

For citations:

Cookies policy